BTIS
SUPN icon

BB&T Investment Services’s Supernus Pharmaceuticals SUPN Stock Holding History

BB&T Investment Services’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$30K Sell
759
-9
-1% -$356 0.01% 684
2017
Q3 		$30K Hold
768
– – 0.01% 627
2017
Q2 		$32K Buy
768
+210
+38% +$7.47K 0.01% 556
2017
Q1 		$19K Buy
558
+443
+385% +$11.9K 0.01% 589
2016
Q4 		$2K Buy
+115
New +$2.57K ﹤0.01% 707

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

BB&T Investment Services's SUPN Position: Q4 2017 in Review

BB&T Investment Services reduced its Supernus Pharmaceuticals (SUPN) stake by 1.2% in Q4 2017, selling an estimated $356 and leaving 759 shares worth $30K. The position accounts for 0.01% of the portfolio, ranked #684.

BB&T Investment Services first reported a position in SUPN in Q4 2016 and has held it in 5 quarters since. The position peaked at $32K in Q2 2017. 297 funds tracked by Wall St. Rank hold SUPN as of Q4 2017.

  • BB&T Investment Services held 759 shares of Supernus Pharmaceuticals worth $30K as of Q4 2017.
  • BB&T Investment Services sold 9 Supernus Pharmaceuticals shares in Q4 2017, an estimated $356.
  • Supernus Pharmaceuticals made up 0.01% of BB&T Investment Services's portfolio in Q4 2017, its #684 holding.
  • BB&T Investment Services first reported a position in Supernus Pharmaceuticals in Q4 2016 and has held it in 5 quarters since.
  • BB&T Investment Services's Supernus Pharmaceuticals position peaked at $32K in Q2 2017.
  • 297 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.